Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01945333 · ClinicalTrials.gov registry record · NA
Personalized and Scalable Cognitive Remediation Approaches
A NA study of Schizophrenia and Schizoaffective Disorder, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- NA
- Development phase
- 122
- Enrollment target
- 5
- Study locations
NCT01945333: Completed NA study of Schizophrenia and Schizoaffective Disorder, sponsored by New York State Psychiatric Institute.
NCT01945333 is a NA study of Schizophrenia and Schizoaffective Disorder that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 122 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (44% lower). The trial reports 5 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01945333, a NA study of Schizophrenia and Schizoaffective Disorder, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 122 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this study is to develop and pilot test personalized and scalable approaches to Cognitive Remediation (CR) for schizophrenia and schizoaffective disorder. The intent is to more clearly define the therapeutic targets important to the facilitation of cognitive and functional improvement so that clinicians know how to customize cognitive interventions and deliver treatment in a more effective, efficient and personally relevant manner.
Primary Outcome
Feasibility is measured by enrollment, acceptability of randomization defined as number initiated allocated treatment, retention of subjects defined as number completed allocated treatment
Conditions Studied
Interventions
- BEHAVIORAL Cognitive remediation
Study Locations (5)
New York
- Williamsburg Clinic - Brooklyn
- Institute for Community Living - Brooklyn
- Nyspi/ Cumc - New York
- The Bridge Inc - New York
- FEGS Bronx Mental Health Clinic - The Bronx
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2013-09 |
| Est. Completion | 2019-03-20 |
| Phase | NA |
What the finished NCT01945333 record still lists
NCT01945333 is an interventional study that assigns participants to a tested intervention. The registered 122 participants enrollment target is mid-sized for trials with a published cap, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (44% lower).
The record links to 2 conditions, with Schizophrenia appearing as the primary indexed condition, and to 1 intervention - of which Cognitive remediation is the first listed.
NCT01945333 lists 5 locations in 1 state (New York).
Frequently Asked Questions
What is clinical trial NCT01945333 about?
NCT01945333 is a clinical study titled "Personalized and Scalable Cognitive Remediation Approaches". The purpose of this study is to develop and pilot test personalized and scalable approaches to Cognitive Remediation (CR) for schizophrenia and schizoaffective disorder. The intent is to more clearly define the therapeutic targets important to the facilitation of cognitive and functional improvement...
What is the current status of trial NCT01945333?
This trial is currently completed. It is a NA study. The enrollment target is 122 participants. The study started on 2013-09. Estimated completion is 2019-03-20.
What conditions does trial NCT01945333 study?
This clinical trial studies the following conditions: Schizophrenia, Schizoaffective Disorder.
What interventions are being tested in trial NCT01945333?
The interventions under investigation include: Cognitive remediation (BEHAVIORAL).
Who is sponsoring clinical trial NCT01945333?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01945333 being conducted?
This trial has 5 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Schizophrenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01945333's enrollment target sits among peer trials
122 118th of 315 higher than 197 of 315 other Schizophrenia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Schizophrenia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Taking Action for College Students
RECRUITING · NA
-
Enhancing Prefrontal Oscillations and Working Memory in Early-course Schizophrenia
RECRUITING · NA
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)
RECRUITING · NA
-
Cerebellar Modulation of Cognition in Psychosis
RECRUITING · NA
-
TMS for Inhibition Enhancement in Schizophrenia
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03363373 · 122 participants · Phase 2
Naxitamab for High-Risk Neuroblastoma Patients With Primary Refractory Disease or Incomplete Response to Salvage Treatment in Bone and/or Bone Marrow
- NCT03463954 · 122 participants · NA
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast Tumors
- NCT04503265 · 122 participants · Phase 1
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
- NCT04700527 · 122 participants · Phase 1
The Effects of SCFA Supplementation in Subjects Receiving Abdominopelvic RT: A Randomized Controlled Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia